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Renovascular Hypertension: Factors Affecting the Outcome

Following Surgical Revascularisation

Malik Anas Rabbani, Alia Zaidi, Syed Sohail Ali, Bushra Anas,  

Asmooni Younus, Syed Mansoor Ahmad Shah 

Department of Medicine, The Aga Khan University Hospital, Karachi, Pakistan 

ABSTRACT. This study was conducted at the Aga Khan University Hospital, Karachi, 
Pakistan to evaluate factors that affect outcome following revascularisation in patients with 
renovascular hypertension. We included all the patients diagnosed to have renovascular 
hypertension, confirmed by renal angiography, between July 1997 and September 2000. Of 
the total 15 patients, nine were males and six were females. Eleven patients received venous 
grafts, three received polytetraflouroethyline (PTFE) grafts while one patient underwent 
angioplasty and stenting. All were followed-up for a period of nine months (median) with 
the range from 2 to 84 months. A total of 33.3% of the study patients were completely 
cured, as they became normotensive without anti-hypertensive therapy after operation, 
while 27% showed marked improvement in blood pressure control post-operatively. Thus, 
extended cure or improvement of renovascular hypertension was achieved in 60% of 
patients. Normal pre-operative serum creatinine level, high pre-operative unstimulated 
peripheral renin levels and renal vein renin ratio of at least 1.75:1 were the most significant 
predictive factors for favorable outcome (p <0.012). The pre-operative severity and 
duration of hypertension as well as degree of disparity in kidney sizes did not predict the 
post-operative improvement in renal function and blood pressure control.  
Key words: Renovascular hypertension, Angiography, Surgical revascularisation,  
                   Renal vein renin ratio, Unstimulated peripheral renin level. 
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  Renovascular hypertension (RVH) is the Dr. Malik Anas Rabbani 
Consultant Nephrologist most common form of secondary hyper­1 
Department of Medicine tension. The exact prevalence of RVH in 
The Aga Khan University Hospital the general population is not known and the 
P.O. Box 3500, Karachi 74800 diagnosis may be missed in many patients. 
Pakistan. It is important to diagnose this condition at an 
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early stage since it is a potentially curable form 
of hypertension, apart from being a potentially 
reversible cause of chronic renal failure.  
  After angioplasty for RVH, about 80% of 
patients require less medication for control 
3of hypertension while in about 48% of 
these patients, no anti-hypertensive therapy 
4is required after the procedure. 
  The major difficulty in curing RVH however, 
is identification of the patients with disease. 
There are no clinical characteristics that 
distinguish patients with RVH from those 
with essential hypertension with any degree 
of certainty. However, there are several 
features that suggest the presence of RVH. 
They are: 
a) Recent onset of hypertension 
b) Age less than 30 or greater than 50 years 
c) Accelerated or malignant hypertension 
d) Sever hypertensive retinopathy 
e) Refractory hypertension 
f) Abdominal or flank bruit
  The physical sign that correlates best with 
the presence of renal artery stenosis is an 
abdominal or flank bruit. Approximately two-
third of patients have occlusive changes in the 
renal arteries due to atherosclerosis and the 
remaining one-third have changes due to 
fibromuscular dysplasia.
  Surgical revascularization is an established 
method of treating patients with severe hyper­
tension and/or renal insufficiency resulting 
from renal artery occlusive disease. With 
the availability of effective anti-hypertensive 
medications and the use of percutaneous 
angioplasty in the treatment of certain patients 
with stenotic renal arteries, the role of surgical 
treatment has become less clear. 
Patients and Methods
  This study was conducted at the Aga Khan 
University Hospital. It included all the 
patients diagnosed to have RVH confirmed 
by renal angiography between the years 1997 
and 2000. Patients with extrinsic compression 
of renal arteries or stenosis of renal graft 
vessels were excluded. 
  Record files were reviewed and the following 
data were noted: age, sex, clinical presentation, 
laboratory investigations including serum 
creatinine (SCr), serum electrolytes, ultrasound 
of the kidneys, duplex scan, captopril DTPA 
scan and conventional angiography. Pre- and 
post-operative blood pressure recordings, renal 
function and renal and peripheral venous 
samples for renin estimation were also 
assessed. All the data was analyzed using 
SPSS software (Release 8.0, standard version, 
copyright c SPSS; 1989-97). Using paired-
sample T test, several pre-operative factors 
including duration of hypertension at the time 
of presentation, renal vein renin ratio (affected 
versus non-affected kidney), disparity in 
kidney sizes, renal function at the time of 
presentation and unstimulated peripheral renin 
levels were analyzed for their ability to 
predict post-operative improvement of blood 
pressure and renal functions. 
  For descriptive purposes patients were 
divided into cured, improved and failure 
groups. Cure was defined as normalization of 
renal function and blood pressure without 
the need for any anti-hypertensive therapy. 
Improvement was defined as a >20% decrease 
in post-operative SCr and post-operative blood 
pressure of less than  160/100 but greater than 
140/90 mm Hg. Failure was defined as rise 
in SCr of > 20% as compared to pre-operative 
levels and blood pressure of >160/100 in 
the post-operative phase. 
Results 
Demographic features
  The clinical and biochemical data from 15 
patients with RVH who were subsequently 
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operated upon and followed-up for a period 
of nine months (median) with a range of 2 
to 84 months are summarized in Table 1. 
There were nine males and six females. Of 
them, 11 patients received vein grafts, three 
received polytetraflouroethyline (PTFE) grafts 
while one patient underwent angioplasty and 
stenting. According to criteria set before 
starting the study, five patients were cured, 
four showed improvement while six patients 
showed no improvement. Thus, nine out of the 
15 patients (60%) benefited from the surgical 
interventions. The mean age of the cured group 
was 45 years (range 15-64 years), 30 years 
(range 22-38) in the improved group and 35 
years (range 27-52 years) in the failure group. 
Renal Function 
In the cured group, renal function was normal 
in three patients at the time of presentation 
while it was abnormal in two patients. Renal 
function normalized in one and showed marked 
improvement in the other patient, over a period 
of nine months.  
In the improved group, the SCr was high in 
three of the four patients (SCr range 150.3 ­
344.8 µmol/L) and normal in one patient at the 
time of presentation. Of the three patients with 
high SCr at presentation, the values normalized 
in one patient post-operatively and showed 
marked improvement in the other two patients 
over the period of follow-up.  
  Four of the six patients in the failure group 
had high SCr at the time of presentation, 
(mean 220 µmol/L, range 141.4-221 µmol/L) 
and all of them showed further worsening over 
a mean period of 17 months. In the remaining 
two patients, the renal function was normal 
at the time of presentation but deteriorated 
over a mean period of four months.  
Blood pressure (BP)
  The mean pre-operative BP was 183/111 mm 
Hg in the cured group, 220/128 mm Hg in 
the improved group and 188/106 mm Hg in 
the failure group. The mean duration of hyper­
tension in the cured group was 60 months, 
in the improved group 74 months and in the 
failure group it was 106 months.  
Disparity in kidney size
  The mean disparity in kidney size in the 
cured group was 2.9 cm (range 2-4), in the 
improved group it was 2.5 cm and in the 
failure group, it was 2.33 cm (range 0.0-4.10). 
Renal vein renin ratio (RVRR)
  The mean renal vein renin ratio (affected 
to non-affected kidney) in the cured group was 
3.23:1 (range 2.50-5.50: 1). In the improved 
group the ratio was 1.96:1 (range 1.75-2.2: 1) 
and in the failure group it was 0.83:1 (range 
0.51-1.1: 1). 
Peripheral Renin Level
  Mean peripheral renin level in the cured 
group was 10.72 ng/ml/hr/ (range 8.2-15.5),  
in the improved group, 15.2 ng/ml/hr (range 
10.0-19.7) and in the failure group it was 
5.13 ng/ml/hr  (range 4.1-6).  
Discussion
  Renovascular hypertension is the most 
common curable form of high blood pressure. 
Several new concepts have emerged in recent 
years relative to atherosclerotic renal artery 
stenosis. Most notably, the indications for 
intervention have changed. 5,6 The enhanced 
efficacy of medical anti-hypertensive therapy 
has decreased the number of patients who 
require intervention solely to treat renovas­
cular hypertension. 
  On the other hand, recent studies of the 
natural history of atherosclerotic renal artery 
stenosis have shown that progressive vascular 
obstruction occurs commonly in patients 
treated medically and in most of cases leads 
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7 to deterioration of renal function. This 
information has reinforced the importance of 
relieving renal arterial obstruction to preserve 
7
renal function in these patients. However, 
in some patients with atherosclerotic reno­
vascular disease, it is difficult to determine 
whether the hypertension is truly renovascular 
or the progression of atherosclerosis due to 
long standing hypertension caused the renal 
artery stenosis. Thus, more extensive investi­
gations, particularly in elderly patients, may 
be necessary to confirm the renovascular 
mechanism of hypertension before surgical 
treatment is recommended. 
  While patients with atherosclerotic renal 
artery stenosis were formerly considered high­
8risk candidates for operative therapy, it has 
been demonstrated that surgical revasculari­
zation can now be done safely and success­
fully even in older patients with extensive 
9-11 extra-renal vascular disease. This has been 
accomplished predominately through vigorous 
preliminary screening and correction of existing 
coronary or cerebrovascular occlusive disease. 
In addition, the development of more effective 
techniques for surgical revascularization has 
made possible operating even on a badly 
12 diseased abdominal aorta. 
In our study, the long-term clinical outcome 
following surgical revascularization in terms 
of blood pressure response and post-operative 
renal function was evaluated. Extended cure 
or improvement of RVH was achieved in 
60% of patients with low pre-operative SCr 
level, renal vein renin ratio of at least 1.75:1 
and high unstimulated peripheral renin 
levels all of which constituted significant 
predictive factors for the outcome (p <0.012). 
Of the 15 patients in the series, 33% were 
completely cured, as they became normoten­
sive after operation without anti-hypertensive 
therapy, while 27% showed marked improve­
ment in blood pressure control post-opera­
tively needing less medications. 
  These results compare favorably to those 
of Laurie et al who noted a favorable blood 
pressure response to surgical revascularisation 
in 82% of 919 patients, followed-up for a 
13 period of six years. However, when both 
kidneys are involved the situation becomes 
more complex as there is no normal kidney to 
excrete the retained sodium and water. In such 
patients, the renin and aldosterone levels may 
become normal but hypertension persists 
because of the increased plasma volume.  
In a compilation of 58 different series of 
patients, Rudnik et al calculated a sensitivity 
of 80% and specificity of 62% for renal vein 
14 renin ratio. Our study has shown that indi­
viduals with renal vein renin ratio of at least 
1.75:1 have either marked improvement or 
complete cure.  
  Disparity in kidney sizes as well as severity 
and duration of hypertension did not affect 
the overall post-operative results.  
Conclusion
  The results of this study confirm the long-
term effectiveness and safety of renovas­
cular reconstruction in the relief of severe 
hypertension. The results further suggest that 
normal renal function and renal vein renin 
ratio of at least 1.75:1 and high unstimulated 
peripheral renin levels at the time of presen­
tation are associated with most favorable 
post-operative outcome. Pre-operative severity 
and duration of hypertension and degree of 
disparity in kidney sizes do not seem to 
affect the overall results in terms of post­
operative improvement in renal function 
and blood pressure control. 
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